BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32631501)

  • 1. Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?
    Garraud O
    Transfus Apher Sci; 2020 Aug; 59(4):102858. PubMed ID: 32631501
    [No Abstract]   [Full Text] [Related]  

  • 2. Active Therapy with Passive Immunotherapy May Be Effective in the Fight against COVID-19.
    Morabito CJ; Gangadharan B
    Clin Transl Sci; 2020 Sep; 13(5):835-837. PubMed ID: 32420691
    [No Abstract]   [Full Text] [Related]  

  • 3. Passive antibody therapy in COVID-19.
    Abraham J
    Nat Rev Immunol; 2020 Jul; 20(7):401-403. PubMed ID: 32533109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of COVID-19 Virus Infection by Convalescent Plasma.
    Cheraghali AM; Abolghasemi H; Eshghi P
    Iran J Allergy Asthma Immunol; 2020 May; 19(S1):3-6. PubMed ID: 32534509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convalescent serum lines up as first-choice treatment for coronavirus.
    Sheridan C
    Nat Biotechnol; 2020 Jun; 38(6):655-658. PubMed ID: 32358594
    [No Abstract]   [Full Text] [Related]  

  • 6. The resurgence of convalescent plasma therapy.
    The Lancet Haematology
    Lancet Haematol; 2020 May; 7(5):e353. PubMed ID: 32359447
    [No Abstract]   [Full Text] [Related]  

  • 7. The convalescent sera option for containing COVID-19.
    Casadevall A; Pirofski LA
    J Clin Invest; 2020 Apr; 130(4):1545-1548. PubMed ID: 32167489
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19.
    Luetkens T; Metcalf R; Planelles V; Zheng Y; Larragoite ET; Spivak ES; Spivak AM; Steinbach M; Blaylock RC; Avila SV; Hankey KG; Martins TB; Slev PR; Mannuel HD; Sajadi M; Rapoport AP; Atanackovic D
    Blood Adv; 2020 Oct; 4(19):4864-4868. PubMed ID: 33031540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convalescent plasma - Is it useful for treating SARS Co-V2 infection?
    Ranganathan S; Iyer RN
    Indian J Med Microbiol; 2020; 38(3 & 4):252-260. PubMed ID: 33154232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and SARS Coronavirus 2: Antibodies for the Immediate Rescue and Recovery Phase.
    Halstead SB; Akkina R
    Front Immunol; 2020; 11():1196. PubMed ID: 32574267
    [No Abstract]   [Full Text] [Related]  

  • 11. Convalescent Plasma: Promise for COVID-19 Pandemic.
    Sheikh S; Baig MA
    J Coll Physicians Surg Pak; 2020 Jun; 30(6):88. PubMed ID: 32723468
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges of Convalescent Plasma Therapy on COVID-19.
    Zhao Q; He Y
    J Clin Virol; 2020 Jun; 127():104358. PubMed ID: 32305026
    [No Abstract]   [Full Text] [Related]  

  • 13. Convalescent Plasma: The Relay Baton in the Race for Coronavirus Disease 2019 Treatment.
    Ouyang J; Isnard S; Lin J; Fombuena B; Peng X; Routy JP; Chen Y
    Front Immunol; 2020; 11():570063. PubMed ID: 33072111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convalescent plasma therapy for COVID-19: a tried-and-true old strategy?
    Xi Y
    Signal Transduct Target Ther; 2020 Sep; 5(1):203. PubMed ID: 32934211
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence lags behind excitement over blood plasma as a coronavirus treatment.
    Ledford H
    Nature; 2020 Aug; 584(7822):505. PubMed ID: 32820261
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody-based therapies for COVID-19: Can Europe move faster?
    Kazatchkine MD; Goldman M; Vincent JL
    PLoS Med; 2020 May; 17(5):e1003127. PubMed ID: 32369479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Disillusioned Comfort with COVID-19 and the Potential of Convalescent Plasma and Cell Therapy.
    Borlongan MC; Borlongan MC; Sanberg PR
    Cell Transplant; 2020; 29():963689720940719. PubMed ID: 32841042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Audio Interview: Capitalizing on Immune Responses to Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 May; 382(21):e93. PubMed ID: 32433859
    [No Abstract]   [Full Text] [Related]  

  • 19. Convalescent plasma in Covid-19: Possible mechanisms of action.
    Rojas M; Rodríguez Y; Monsalve DM; Acosta-Ampudia Y; Camacho B; Gallo JE; Rojas-Villarraga A; Ramírez-Santana C; Díaz-Coronado JC; Manrique R; Mantilla RD; Shoenfeld Y; Anaya JM
    Autoimmun Rev; 2020 Jul; 19(7):102554. PubMed ID: 32380316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities.
    Farrugia A
    Transfus Clin Biol; 2020 Aug; 27(3):167-168. PubMed ID: 32563550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.